Related Experiment Videos
[Gaucher's disease and enzyme replacement therapy]
1Genzyme SA, Cergy-Pontoise.
Annales Pharmaceutiques Francaises
|October 14, 1998
Summary
Gaucher disease, a genetic disorder, results from glucocerebrosidase enzyme deficiency. Enzyme replacement therapy has shown significant improvements in patients, including those in France.
Area of Science:
- Biochemistry
- Genetics
- Hematology
Context:
- Gaucher disease is an autosomal recessive genetic disorder.
- Characterized by glucocerebrosidase enzyme deficiency leading to glucocerebroside accumulation in macrophages (Gaucher cells).
- Clinical manifestations include anemia, thrombocytopenia, organomegaly, and bone problems.
Purpose:
- To describe the pathophysiology of Gaucher disease.
- To highlight the discovery of the enzyme deficiency and the development of enzyme replacement therapy.
- To report on the treatment outcomes in a patient population.
Summary:
- Deficiency of the glucocerebrosidase enzyme causes Gaucher disease, leading to cellular accumulation and various health issues.
- Enzyme replacement therapy, developed following the discovery of the enzyme deficiency, offers a treatment option.
- The therapy has benefited approximately 1,600 patients globally, with notable improvements observed in treated French patients.
Impact:
- Enzyme replacement therapy has significantly improved the quality of life for Gaucher disease patients.
- The treatment demonstrates the success of targeted therapies for genetic disorders.
- Further research may focus on expanding treatment accessibility and efficacy.